Skip to main content
Gynecology Billing: How a Maryland Practice Recovered $42,700 That Was Walking Out of the Supply Cabinet - LARC Device J-Codes, Modifier 25 and HealthChoice Rules
A four-provider gynecology practice in Silver Spring, Maryland runs a large long-acting reversible contraception (LARC) program alongside its well-woman and in-office procedure volume. The practice was purchasing IUDs and contraceptive implants at roughly $900–$1,300 each, placing them, billing the insertion CPT — and never billing the device itself.
MZ Medical Billing performed a focused gynecology billing audit and found LARC devices leaving the supply cabinet without corresponding claim lines, well-woman visits that had become problem visits without modifier 25, and Medicare patients being billed with commercial preventive codes despite receiving accurate coverage guidance through the Maryland Department of Aging’s Medicare support program. The review also found same-day procedures where the E/M was bundled away.
The audit also identified Maryland-specific billing issues, including HealthChoice device claims missing required information, inconsistent contraceptive management diagnoses, and a small number of no-cost devices that had been billed as purchased inventory.
This gynecology billing case study explains how MZ Medical Billing reconciled device purchase records against claims, rebuilt LARC charge capture, corrected recoverable coding and payer issues, and established a device-to-claim ledger. The cleanup recovered $42,700, increased the clean claim rate from 87% to 97%, raised LARC device capture from 44% to 100%, and reduced same-day E/M bundling denials by 64%.
The Practice and the Charge That Never Existed
The client is a four-provider gynecology practice — three physicians and one women’s health nurse practitioner — serving a dense and unusually diverse Montgomery County population. Their case mix is gynecology-forward: well-woman exams, contraceptive management, colposcopy, endometrial biopsy, in-office hysteroscopy, pessary management, and a LARC program large enough that the practice keeps a stocked device cabinet on site.
That cabinet is where the story starts. When a practice buys and stocks LARC devices — hormonal IUDs, the copper IUD, the etonogestrel implant — it is doing what infusion and pharmacy practices call buy-and-bill. The practice pays for the device up front, places it, and is supposed to be reimbursed for two separate things: the professional work of the insertion (CPT 58300 for an IUD, 11981 for an implant) and the device itself, billed as a HCPCS supply code — J7297, J7298, J7300, J7301 or J7307 depending on which product was placed.
This practice was billing the first and not the second. Not occasionally — routinely. Not because anyone decided to, but because the encounter form and the EHR procedure template contained the insertion code and nothing else. Staff genuinely believed the device came bundled with the insertion, or that the health plan supplied it. On a device with four-figure acquisition cost, that assumption isn’t a rounding error. It is the practice buying inventory and giving it away.
Nothing about this was hidden or obscure. The Maryland Department of Health publishes general billing information that treats a supplied product and a professional service as what they are — two distinct things a provider bills for. The rules were never the problem. The problem was that no one in the practice had ever asked whether the claim leaving the building actually contained both of them.
The only place that loss is visible is in the gap between the purchase order and the claim, and almost nobody looks there. Across the review period the practice’s clean claim rate on gynecology claims sat at 87%, and the partners had concluded their margin problem was a contracting problem. It wasn’t. They engaged MZ Medical Billing to rebuild device capture, modifier discipline and Maryland-specific payer routing across the entire gynecology book. Our team had the reconciliation running inside three weeks.
Six Gynecology Billing Failures — Five Cost Money, One Cost Sleep
The audit reviewed a full period of gynecology encounters, procedure notes, device purchase records and remittances side by side — that last step being the one almost no audit performs. Six failures surfaced. Five were quiet revenue leaks. The sixth was the mirror image: money the practice had collected that it should not have.
The practice purchased IUDs and implants, stocked them, placed them, and billed only the insertion CPT. The device HCPCS line — J7297, J7298, J7300, J7301 or J7307 — was absent from most claims because it had never been added to the encounter template. On a device with four-figure acquisition cost, every omitted line is the full purchase price absorbed as practice overhead.
A preventive gynecology exam constantly turns into something else: the patient mentions abnormal bleeding, pelvic pain or a new lump, and the provider works it up. When that problem-focused work is significant and separately identifiable it is separately payable alongside the preventive code with modifier 25. This practice billed the preventive visit alone and documented the problem work in the same undifferentiated note.
Medicare does not pay the commercial preventive medicine codes. It has its own gynecology screening benefit: G0101 for the pelvic and clinical breast examination and Q0091 for obtaining and conveying the screening Pap specimen. The practice billed 99397 to Medicare patients, watched it reject as non-covered, and wrote it off — for years, across an entire cohort of established patients.
When a patient is evaluated and then has a procedure the same day — endometrial biopsy 58100, colposcopy 57454/57455/57456, LEEP 57460/57461, in-office hysteroscopy 58558 — the evaluation is often a separately identifiable service. Without modifier 25 and a note that visibly separates the evaluation from the procedure, edits bundle the E/M away.
Maryland Medicaid is delivered through HealthChoice managed care organizations, and the state’s provider billing rules expect physician-supplied product lines to carry the National Drug Code and correct units alongside the HCPCS code. On the occasions this practice did bill a device to a HealthChoice plan, the NDC was missing and the contraceptive management diagnosis (Z30.–) was inconsistently applied. The line came back denied, and the denial was read as a coverage answer rather than a formatting one.
A small number of devices had come to the practice at no acquisition cost through manufacturer patient-assistance channels — and were billed as though the practice had bought them. That is not revenue; it is a repayment obligation with compliance teeth. Separately, self-pay patients scheduling in-office procedures were never issued Good Faith Estimates.
One Appointment, Three Independent Billing Layers
Most specialties bill one thing per visit. Gynecology routinely stacks three — a preventive service, a problem service, and a procedure with a physical product attached — inside a single twenty-minute appointment. Each layer has its own code set, its own rules, and its own way of vanishing. Seeing them as separate layers is the whole discipline of gynecology billing.
Commercial plans use age-based preventive medicine codes. Medicare uses G0101 and Q0091 on its own frequency schedule instead. And the uninsured patient is a third case again — entitled to a written estimate before the visit under the No Surprises Act, which Maryland health systems have been publishing patient guidance on for years. Identical clinical exam, three entirely different claims.
Significant, separately identifiable problem work performed alongside the preventive service is its own E/M, reported with modifier 25. It is an accuracy tool, not a billing trick — but it survives review only when the documentation shows two distinguishable pieces of work rather than one blended narrative.
J7297 and J7298 for 52 mg hormonal IUDs, J7301 for the 13.5 mg system, J7300 for the copper IUD, J7307 for the etonogestrel implant. When the practice buys and stocks these, the device is reimbursed on its own line, with its own units and, for most Medicaid plans, its own NDC.
Rebuilding Documentation — Two Services Need Two Visible Pieces of Work
In gynecology the chart note has to do something unusual: prove that more than one distinct service happened inside one appointment, and record what physical product was consumed. The old notes did neither. They were clinically excellent and financially mute.
- Preventive and problem work blended into a single undivided narrative
- No device brand, dose, lot or NDC recorded at the point of placement
- No note of whether the device was purchased stock or supplied at no cost
- Specimen collection for Q0091 not documented as its own act
- Same-day evaluation not distinguishable from the procedure it preceded
- Contraceptive management (Z30.–) diagnosis inconsistently attached
- Preventive and problem-focused sections physically separated in the note
- Device brand, dose, lot number and NDC captured at placement, not later
- Acquisition source flagged: purchased stock vs supplied at no cost
- Screening Pap collection documented discretely to support Q0091
- Pre-procedure evaluation written as its own assessment and plan
- Z30.– contraceptive management linked to every LARC encounter
From the Purchase Order to the Remittance — The Full Path, Rebuilt
A gynecology claim with a device attached doesn’t begin at the visit. It begins when the practice spends money on inventory — and it isn’t finished until that specific unit has been matched to a paid claim line.
Every device entering the cabinet is logged with cost, lot, NDC and acquisition source, so it has an identity before it is ever used.
Contraceptive and device benefits verified before placement — plus a Good Faith Estimate for any scheduled self-pay procedure.
The note separates preventive from problem work and records exactly which device unit left the cabinet.
Procedure CPT, device HCPCS, units, NDC, diagnosis and modifier 25 assembled on the correct payer’s rules.
Every device that left the cabinet is matched to a billed and paid line. Unmatched units become an open task, not a loss.
The structural insight is simple and, in our experience, almost never applied: in a buy-and-bill gynecology practice, inventory is accounts receivable. A device sitting in a patient with no corresponding claim line is functionally identical to a claim that was never submitted — except that it also cost the practice real cash to acquire. Treating the supply cabinet as the first stage of the revenue cycle, rather than an operational afterthought, is where most of this recovery came from.
Why the Same Gynecology Visit Bills Four Different Ways in Maryland
Gynecology billing in Maryland means running one clinical service across four payer worlds, each of which handles preventive care, contraceptive devices and patient estimates differently. One blanket workflow across all four is exactly what generated the denials.
Contraceptive services and devices generally covered as preventive with no patient cost-share — which removes the patient friction that would otherwise expose a missing device line.
State billing rules plus MCO-specific requirements: correct HCPCS, units, NDC and a Z30.– diagnosis on every device line, or the line denies.
A separate screening benefit with its own codes and frequency limits — the commercial preventive medicine codes are simply not payable.
Uninsured and self-pay patients scheduling procedures are entitled to a Good Faith Estimate — and practices that issue them collect far more of what they bill.
On the commercial side, most plans cover contraceptive services and devices as preventive care with no patient cost-sharing, which creates a specific trap: because the patient pays nothing, nobody in the office is watching the money, and a missing device line produces no phone call and no complaint. Free-to-the-patient is not free-to-the-practice, and the absence of patient friction is precisely why this leak survives for years undetected.
Maryland Medicaid operates through HealthChoice managed care organizations, and the state publishes its own provider billing rules alongside the Department of Health’s broader billing guidance. For device lines the practical requirements are unforgiving in a very ordinary way: the right HCPCS code, the right unit count, the National Drug Code, and a contraceptive management diagnosis that matches the service. Miss one element and the line denies — and a denied device line that nobody reworks is indistinguishable, on the P&L, from a device that was never billed at all.
Medicare adds a third rule set through G0101 and Q0091 on their own frequency schedule, and Maryland patients navigating that coverage are frequently better briefed than the front desk — which means a practice that bills these visits incorrectly gets contradicted by its own patient. Self-pay is the fourth lane, governed by the Good Faith Estimate requirements described earlier. And underneath all of it sits Maryland’s distinctive all-payer hospital rate-setting environment, which changes the economics of whether a gynecology procedure belongs in the office or in a hospital outpatient department — a site-of-service question most practices in other states never have to model this carefully.
Working Backwards — Recovering Charges That Were Never Created
Appealing a denial is routine. Recovering a charge that was never submitted is a different exercise: it means rebuilding claims from clinical and purchasing records, inside timely filing windows, before the opportunity expires. That work ran on a four-step ladder — and the last step gave money back.
We reconciled device purchase records against submitted claims to identify every unit that had been placed but never billed, then rebuilt corrected claims with the proper HCPCS code, units and NDC for each encounter still inside its payer’s timely filing window — prioritized by filing deadline so the shortest windows were worked first.
Bundled same-day E/M denials were appealed with documentation demonstrating the evaluation was significant and separately identifiable from the procedure or preventive service. Where the original note couldn’t support it, we said so and left the claim alone rather than dressing it up.
Previously abandoned Maryland Medicaid device denials were corrected with the missing NDC, accurate unit counts and the contraceptive management diagnosis, then resubmitted through the correct MCO channel — converting a write-off category into a recovery category.
The devices obtained at no acquisition cost that had been billed as purchased were identified and refunded proactively, with the correction documented. This step reduced the reported recovery figure — and it was non-negotiable. A practice that self-corrects on its own timeline is in a materially different position than one that is found.
The Device-to-Claim Ledger — Nothing Leaves the Cabinet Without a Claim Line
This is the control that made the difference, and it is the one thing from this engagement we now build for every buy-and-bill gynecology practice we take on. It is not sophisticated. It is a reconciliation almost nobody performs, because inventory and billing live in different systems and report to different people.
Before the rebuild, devices were ordered by clinical staff and billed — when billed at all — by the billing team, with no shared record connecting the two. A unit could be purchased, stocked, placed and clinically documented without a single financial system ever knowing it had existed.
That is the structural failure, and it is not unique to this practice. Supply is an operational function. Billing is a financial function. In most gynecology practices nothing sits between them, so the only signal that a device was never billed is an unexplained gap in margin — which gets attributed to contracts, payer mix, or overhead, because those are the explanations that come with reports attached.
The ledger closes that gap by giving every device unit a life cycle that ends at a paid claim line. A missing charge now behaves exactly like a denial: it becomes visible, assigned, dated and worked.
- Every device logged with cost, lot, NDC and acquisition source
- Placement in the chart auto-linked to the device HCPCS line
- Unmatched units flagged and worked before timely filing expires
- No-cost devices blocked from being billed as purchased stock
- Monthly reconciliation: units consumed versus lines paid
- Device capture reported as a standing metric, not an audit finding
How We Rebuilt Gynecology Billing Phase by Phase
The rebuild followed the money backwards — starting where the practice spent cash, not where it submitted claims. Each phase closed one or more of the six failures and left behind a control the practice now runs itself.
We began with purchasing records rather than claims. Every LARC unit was given an identity at intake — cost, lot, NDC, acquisition source — and the encounter template was rebuilt so the device HCPCS line is created automatically the moment a placement is documented.
- Device HCPCS line added to every LARC encounter template
- Units and NDC captured at placement, not reconstructed later
- Device capture moved from 44% of units to 100%
The gynecology note was restructured so preventive care, problem-focused work and same-day procedures occupy visibly distinct sections. Modifier 25 is now applied where documentation genuinely supports a significant, separately identifiable service — and deliberately withheld where it doesn’t.
- Preventive and problem sections separated in the template
- Pre-procedure evaluation documented as its own assessment
- Same-day bundling denials reduced by 64%
Each encounter is now routed to the correct rule set before submission: commercial preventive coding, HealthChoice device requirements with NDC and Z30.– diagnosis, Medicare’s G0101 and Q0091 screening benefit, and a Good Faith Estimate workflow for self-pay procedures.
- Medicare gynecology screening recoded to G0101 / Q0091
- HealthChoice device lines built with NDC, units and diagnosis
- Good Faith Estimates issued to every self-pay procedure patient
Historical encounters were reconciled against purchase records and rebuilt where timely filing still allowed it — devices retro-billed, Medicare screening visits recoded, abandoned HealthChoice device denials corrected and resubmitted. This phase produced the bulk of the $42,700.
- Unbilled device units identified and retro-billed by filing deadline
- Written-off Medicare preventive rejections recoded and rebilled
- HealthChoice device denials reworked instead of written off
The device-to-claim ledger became a monthly standing report, no-cost devices were blocked from purchased-stock billing at the charge-entry level, and the prior no-cost billings were refunded with the correction documented. The practice now watches its own device capture rate the way it watches its collection rate — which is the difference between a project that ends and a control that holds.
- Monthly units-consumed versus lines-paid reconciliation
- No-cost devices blocked at the charge-entry level
- Prior no-cost billings refunded and documented proactively
The Recovery, Broken Down by Source
The recovered $42,700 came from five sources, each tied to a specific failure the rebuild closed. Every dollar traces to a concrete action — a device line created, a modifier earned, a Medicare visit recoded, a Medicaid denial finally reworked. The figure is stated net of the voluntary refunds made in Step 4.
The Gynecology Billing Position, Compared Directly
Eight functions, measured at intake and after the rebuild. Note that the last row is the only one where the number moved in the practice’s favour by moving money out.
| Billing Function | Before Rebuild | After Rebuild | Impact |
|---|---|---|---|
| LARC Device Billing | Insertion billed, device HCPCS line absent from most claims. | Device line auto-created at placement with units, NDC and source. | $16.3K recovered · capture 44% → 100% |
| Well-Woman + Problem Visit | Both services delivered, one billed — modifier 25 never used. | Note separates the layers; modifier 25 applied where earned. | $9.8K recovered on work already performed |
| Same-Day Procedures | E/M bundled into the procedure — the top denial category. | Evaluation documented separately and billed with modifier 25. | $7.4K recovered · bundling denials down 64% |
| Maryland HealthChoice | Device lines denied for missing NDC, then written off. | NDC, units and Z30.– diagnosis on every line; denials reworked. | $5.3K recovered from a former write-off category |
| Medicare Gynecology | Commercial preventive code billed, rejected, written off. | Screening billed as G0101 and Q0091 on the correct frequency. | $3.9K recovered from an abandoned cohort |
| Self-Pay & Estimates | No Good Faith Estimates; patients disputed bills after the fact. | Estimate issued before every scheduled self-pay procedure. | Self-pay collection rate 41% → 76% |
| Clean Claim Rate | 87% on gynecology claims. | 97% on gynecology claims. | A 10-point lift and far less rework per claim |
| Compliance Exposure | No-cost devices billed as purchased stock — unbooked liability. | Blocked at charge entry; prior instances refunded and documented. | Exposure closed through documented self-correction |
What This Engagement Proves About Gynecology Billing
Six conclusions that apply to any gynecology practice stocking devices, stacking services, or running more than one payer type through a single workflow.
Denials get worked because denials arrive. A charge that was never created never arrives — no work queue, no aging bucket, no report. In a buy-and-bill gynecology practice, the single largest leak we find is almost always the one generating zero alerts.
A four-figure device that goes into a patient with no matching claim line is a claim that was never submitted, plus real cash already spent. Until the supply cabinet is reconciled against the remittance, a practice doesn’t know what it billed — only what it collected.
When contraceptive care is covered as preventive and the patient owes nothing, nobody calls to question a bill — so an incomplete claim generates no friction anywhere in the practice. The absence of complaints is not evidence that billing is working.
Gynecology routinely stacks a preventive service, a problem service and a procedure into one appointment. If the note blends them into one narrative, only one can be billed — and if the modifier is applied anyway, it will not survive review. Separate the work in the note, or don’t bill it.
The same well-woman visit is a commercial preventive claim, a HealthChoice claim with NDC requirements, a Medicare G0101/Q0091 claim, or a self-pay encounter needing a Good Faith Estimate. Running one workflow across all four is a reliable way to manufacture denials.
We reduced this practice’s reported recovery by refunding devices billed but never purchased. Any partner who only ever finds you money isn’t auditing you — and correct gynecology billing means collecting everything earned and nothing that wasn’t.
Questions Gynecology Practices Ask Most
These are the questions we field most often about device billing, same-day services and Maryland’s payer rules — answered the same way we answered them for this Silver Spring group.
Yes — when your practice purchased and stocked the device. The insertion CPT (58300 for an IUD, 11981 for a contraceptive implant) pays for the professional work. The device itself is billed on its own line using the applicable HCPCS supply code — J7297, J7298, J7300, J7301 or J7307 depending on the product — with correct units and, for most Medicaid plans, the National Drug Code. Billing the insertion alone leaves the largest dollar amount on the claim uncollected, and because it produces no denial, most practices never notice.
When the problem-focused work is significant and separately identifiable from the preventive service — a new complaint requiring its own history, examination and medical decision-making, not a question answered in passing. Reported with modifier 25 on the problem E/M, this is entirely appropriate coding. What determines whether it holds up is the note: the preventive and problem work need to be visibly distinct, with their own assessment and plan. A blended narrative supports one service, no matter which modifier is attached.
Because Medicare does not cover the commercial preventive medicine codes at all. It has its own screening benefit: G0101 for the cervical or vaginal cancer screening pelvic and clinical breast examination, and Q0091 for obtaining and conveying the screening Pap specimen, each on its own frequency schedule. Practices that bill 99397 to Medicare get a non-covered rejection, and many then write the visit off entirely — abandoning a payable service for an entire patient cohort. Recoding is usually all that is required.
In practice, yes — the device line has to be complete. That means the correct HCPCS code, an accurate unit count, the National Drug Code, and a contraceptive management diagnosis (Z30.–) consistent with the service, submitted under the rules the state publishes for Medicaid providers and the requirements of the specific HealthChoice MCO. A line missing any of those elements will deny, and the most common failure we see isn’t the denial itself but what happens next: the line gets written off as “not covered” rather than corrected and resubmitted.
No. If your practice did not incur the acquisition cost — the device came through a manufacturer patient-assistance channel, a replacement program, or was otherwise supplied at no charge — billing a payer as though you purchased it creates a repayment obligation and real compliance exposure. This is why acquisition source belongs in your device log and your chart note, not in someone’s memory. The control is simple: no-cost units should be blocked at charge entry so the question never reaches the claim.
If the patient is uninsured or choosing not to use their insurance, the No Surprises Act generally requires that they receive a Good Faith Estimate of expected charges for scheduled care. Beyond compliance, it is one of the highest-return operational changes a gynecology practice can make: patients who see a number before the procedure pay it far more reliably than patients who receive a surprise statement afterward. In this engagement, issuing estimates moved self-pay collections from 41% to 76% without changing a single price.
“This practice wasn’t losing money to denials. It was losing money to charges that were never created — which is worse, because nothing in a billing system will ever tell you they’re missing. They were buying four-figure devices, placing them, and billing only the insertion. We reconciled the purchase ledger against the claims, rebuilt the encounter template so the device line creates itself, separated preventive from problem work so modifier 25 became defensible, recoded the Medicare screening cohort, and reworked HealthChoice device denials that had been sitting as write-offs. We also refunded the devices they’d billed but never paid for — that reduced our own number, and it was the right call. Clean claims went from 87% to 97%, device capture from 44% to 100%, and we recovered $42,700 that had literally walked out of a cabinet.”MZ Medical Billing — Gynecology Billing Case Summary, LARC Device Capture, Maryland 2026
I want to be honest about how uncomfortable this was, because I think other practices need to hear it. We are four providers, we place a lot of LARC, and we were billing the insertion and nothing else. Not sometimes. Routinely. We had convinced ourselves the device came with the plan.
What still bothers me is that nothing ever told us. There was no denial. No rejected claim. No angry patient, because these patients owe nothing at the counter. It just quietly wasn’t on the claim, and a charge that doesn’t exist doesn’t show up on any report I have ever been handed.
MZ found it by doing something none of our previous billers had done — they asked our office manager for the device purchase records and laid them next to the claims. The gap was immediate and it was awful. They rebuilt our templates so the device line creates itself, went back and retro-billed everything still inside filing limits, recoded our Medicare annuals we had been writing off for years, and reworked Medicaid device denials our old team had marked as not covered.
They also told us we had billed a small number of devices we had received at no cost, and that we needed to refund them. That lowered their own recovery number. I trusted everything else they told me after that. Clean claims went from 87% to 97%, and they recovered $42,700 from a cabinet in a back hallway.
How Many Devices Left Your Cabinet Without a Claim Line?
If your practice buys and stocks LARC devices, there is a number that answers this question — and most practices have never calculated it. Missing device lines, blended preventive and problem notes, written-off Medicare annuals and abandoned Medicaid device denials quietly cap what a gynecology practice collects. MZ Medical Billing’s gynecology billing services team reconciles your purchase ledger against your remittances and rebuilds the workflow end to end — so you collect everything you’ve earned, and nothing you haven’t.